diabetes glp-1 agonist New Guidelines for Type 2 in 2025 GLP1 Receptor Agonists—Effects beyond Obesity
Description
Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus
The exocrine pancreas has GLP-1 receptors, mainly on the acinar cells
[4] Ward, Z
Prioritizing rest and relaxation makes medication work better
This approach emphasized the use of cardioprotective GLP-1 RAs [liraglutide, dulaglutide, semaglutide, and albiglutide (withdrawn from the market for business reasons)] in T2DM patients with or at high risk for atherosclerotic CVD (ASCVD), heart failure (HF), or chronic kidney disease (12)
Clinical evidence demonstrates significant therapeutic benefits of GLP-1RAs in the management of psoriasis
